Rationale and Study Protocol of the Physical Activity and Dietary Intervention in Women with OVArian Cancer (PADOVA) Study: a Randomised Controlled Trial to Evaluate Effectiveness of a Tailored Exercise and Dietary Intervention on Body Composition,...

Overview

Journal BMJ Open

Specialty General Medicine

Date 2020 Nov 5

PMID 33148722

Citations 13

Authors

Stephanie Stelten

Meeke Hoedjes

Gemma G Kenter

Ellen Kampman

Rosalie J Huijsmans

Luc Rcw van Lonkhuijzen

L M Buffart

Affiliations

Soon will be listed here.

Abstract

Introduction: As a consequence of ovarian cancer and its treatment, many women with ovarian cancer have to deal with reduced physical function, fatigue, and loss of weight and/or muscle mass, compromising quality of life. Exercise and dietary interventions can positively influence body composition, physical fitness and function, and fatigue in patients with cancer. However, there are no data from randomised controlled trials on the effectiveness of exercise and dietary interventions in patients with ovarian cancer. Due to a complex disease trajectory, a relatively poor survival and distinct disease-induced and treatment-induced side effects, it is unclear whether exercise and dietary interventions that were shown to be feasible and effective in other types of cancer produce comparable results in patients with ovarian cancer. The aim of this article is to present the design of the multicentre randomised controlled Physical Activity and Dietary intervention in OVArian cancer trial and to describe how the exercise and dietary intervention is tailored to specific comorbidities and disease-induced and treatment-induced adverse effects in patients with ovarian cancer.

Methods And Analysis: Adult women with primary epithelial ovarian cancer who are scheduled to undergo first-line (neo)adjuvant chemotherapy (n=122) are randomly allocated to a combined exercise and dietary intervention or a usual care control group during chemotherapy. Primary outcomes are body composition, physical function and fatigue. Outcome measures will be assessed before the start of chemotherapy, 3 weeks after completion of chemotherapy and 12 weeks later. The exercise and dietary intervention was tailored to ovarian cancer-specific comorbidities and adverse effects of ovarian cancer and its treatment following the i3-S strategy.

Ethics And Dissemination: This study has been approved by the medical ethical committee of the Amsterdam UMC (reference: 018). Results of the study will be published in international peer-reviewed journals.

Trial Registration Number: Netherlands Trial Registry (NTR6300).

Citing Articles

Nutritional status and daily habits as determinants of hospitalization duration in ovarian cancer patients undergoing chemotherapy.

Dan X, Tian Y, Huang Y, He Y, Ren J Sci Rep. 2024; 14(1):27841.

PMID: 39537687 PMC: 11561155. DOI: 10.1038/s41598-024-78941-y.

Study protocol of an exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA) - a randomized controlled trial.

Maurer T, Belau M, Zyriax B, Welsch G, Jagemann B, Chang-Claude J BMC Cancer. 2024; 24(1):1379.

PMID: 39528997 PMC: 11552146. DOI: 10.1186/s12885-024-13102-y.

Efficacy of a WeChat-Based, Multidisciplinary, Full-Course Nutritional Management Program on the Nutritional Status of Patients With Ovarian Cancer Undergoing Chemotherapy: Randomized Controlled Trial.

Tian X, Liu Y, Zhang J, Yang L, Feng L, Qi A JMIR Mhealth Uhealth. 2024; 12:e56475.

PMID: 39496160 PMC: 11554286. DOI: 10.2196/56475.

The combined effect of physical exercise, pranayama, and diet on fatigue in adult cancer patients undergoing chemotherapy: a randomized controlled trial.

Mehta S, Joshi A, Ramteke M, Tandiya P Support Care Cancer. 2024; 32(9):618.

PMID: 39207544 DOI: 10.1007/s00520-024-08821-8.

Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial.

Kenkhuis M, Stelten S, Hartman Y, Brouwer C, Tusscher M, van Lonkhuijzen L Br J Cancer. 2024; 131(1):101-109.

PMID: 38720046 PMC: 11231132. DOI: 10.1038/s41416-024-02694-8.

References

FREEDMAN R, Aziz N, Albanes D, Hartman T, Danforth D, Hill S . Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab. 2004; 89(5):2248-53. DOI: 10.1210/jc.2003-031874. View

Postma T, Aaronson N, Heimans J, Muller M, Hildebrand J, Delattre J . The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005; 41(8):1135-9. DOI: 10.1016/j.ejca.2005.02.012. View

Cohen C, Fontaine K, Arend R, Alvarez R, Leath Iii C, Huh W . A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer. J Nutr. 2018; 148(8):1253-1260. PMC: 8496516. DOI: 10.1093/jn/nxy119. View

Smets E, Garssen B, Bonke B, de Haes J . The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39(3):315-25. DOI: 10.1016/0022-3999(94)00125-o. View

Lane C, Huws-Thomas M, Hood K, Rollnick S, Edwards K, Robling M . Measuring adaptations of motivational interviewing: the development and validation of the behavior change counseling index (BECCI). Patient Educ Couns. 2005; 56(2):166-73. DOI: 10.1016/j.pec.2004.01.003. View

Hess L, Barakat R, Tian C, Ozols R, Alberts D . Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2007; 107(2):260-5. PMC: 2517223. DOI: 10.1016/j.ygyno.2007.06.010. View

Mardas M, Stelmach-Mardas M, Madry R . Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival. Support Care Cancer. 2016; 25(3):795-800. DOI: 10.1007/s00520-016-3462-1. View

Van Waart H, Stuiver M, van Harten W, Geleijn E, Kieffer J, Buffart L . Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial. J Clin Oncol. 2015; 33(17):1918-27. DOI: 10.1200/JCO.2014.59.1081. View

Bolanowski M, NILSSON B . Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit. 2001; 7(5):1029-33. View

10.

Campbell K, Neil S, Winters-Stone K . Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med. 2012; 46(13):909-16. DOI: 10.1136/bjsports-2010-082719. View

11.

Demark-Wahnefried W, Morey M, Sloane R, Snyder D, Miller P, Hartman T . Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors. J Clin Oncol. 2012; 30(19):2354-61. PMC: 3675693. DOI: 10.1200/JCO.2011.40.0895. View

12.

Campbell K, Van Patten C, Neil S, Kirkham A, Gotay C, Gelmon K . Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. J Acad Nutr Diet. 2012; 112(4):559-67. DOI: 10.1016/j.jada.2011.10.022. View

13.

Rutten I, van Dijk D, Kruitwagen R, Beets-Tan R, Olde Damink S, Van Gorp T . Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle. 2016; 7(4):458-66. PMC: 4782251. DOI: 10.1002/jcsm.12107. View

14.

Klein I, Danzi S . Thyroid disease and the heart. Circulation. 2007; 116(15):1725-35. DOI: 10.1161/CIRCULATIONAHA.106.678326. View

15.

Blauwhoff-Buskermolen S, Versteeg K, de van der Schueren M, den Braver N, Berkhof J, Langius J . Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2016; 34(12):1339-44. DOI: 10.1200/JCO.2015.63.6043. View

16.

Kim S, Kim H, Kim T, Suh D, Kim K, No J . Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer. J Immunol Res. 2014; 2014:349546. PMC: 4094724. DOI: 10.1155/2014/349546. View

17.

Kumar A, Bakkum-Gamez J, Weaver A, McGree M, Cliby W . Impact of obesity on surgical and oncologic outcomes in ovarian cancer. Gynecol Oncol. 2014; 135(1):19-24. DOI: 10.1016/j.ygyno.2014.07.103. View

18.

Demark-Wahnefried W, Peterson B, Winer E, Marks L, Aziz N, Marcom P . Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001; 19(9):2381-9. DOI: 10.1200/JCO.2001.19.9.2381. View

19.

Kumar A, Moynagh M, Multinu F, Cliby W, McGree M, Weaver A . Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. Gynecol Oncol. 2016; 142(2):311-6. DOI: 10.1016/j.ygyno.2016.05.027. View

20.

Persoon S, Chinapaw M, Buffart L, Liu R, Wijermans P, Koene H . Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study. PLoS One. 2017; 12(7):e0181313. PMC: 5519072. DOI: 10.1371/journal.pone.0181313. View